22NW LP
Q2 2024 Form 13-F

SEATTLE, WASHINGTON
CIK 0001694297 · CRD 230788 · SEC-registered investment adviser
$117.2M Reported Value Total

22NW, LP reports 1 total accounts under management (AUM). There are 1 discretionary accounts valued at $342,665,331, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
1 fund · $295.6M gross asset value
Hedge Fund: $295.6M
Source: Form ADV filed 2026-03-13
Reported value
$117.2M
Quarter over quarter
-9.3%
Holdings
13
Top-10 concentration
95.7%

Key People

Form ADV owners & control persons
Aron Reid English
LIMITED PARTNER
James Paul Stoner
CFO, CCO

Filing Navigation

13F Metrics

Loading 13F Metrics

Q2 2024 13F record

Q2 2024 13F filing summary

Q2 2024 Form 13F portfolio summary
Period of report June 30, 2024
Filed August 14, 2024
Form 13F-HR
Reported value $117.2M
Positions 13
Change in reported value +1.0%
New positions 2
Exited positions 2
Position turnover 26.7%
Top-10 concentration 95.7%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
15 $144.3M
Q2 2026 13F
Filed Aug 14, 2026
14 $104.7M
Q1 2026 13F
Filed May 15, 2026
16 $145.9M
Q4 2025 13F
Filed Feb 13, 2026
20 $237.6M
Q3 2025 13F
Filed Nov 14, 2025
21 $212.3M
Q2 2025 13F
Filed Aug 14, 2025
21 $158.8M
Q1 2025 13F
Filed May 14, 2025
20 $149.1M
Q4 2024 13F
Filed Feb 14, 2025
16 $158.5M
Q3 2024 13F
Filed Nov 14, 2024
13 $119.3M
Q2 2024 13F
Filed Aug 14, 2024
13 $117.2M
Q1 2024 13F
Filed May 15, 2024
13 $116.1M
Q4 2023 13F
Filed Feb 14, 2024
14 $153.5M
Q3 2023 13F
Filed Nov 14, 2023
13 $140.3M
Q2 2023 13F
Filed Aug 14, 2023
13 $160.1M
Q1 2023 13F
Filed May 15, 2023
16 $162.7M
Q4 2022 13F
Filed Feb 10, 2023
19 $185.2M
Q3 2022 13F
Filed Nov 14, 2022
20 $176.8M
Q2 2022 13F
Filed Aug 12, 2022
20 $188.4M
Q1 2022 13F
Filed May 13, 2022
25 $275.4M
Q4 2021 13F
Filed Feb 14, 2022
25 $323.4M

20 earlier quarters on file — choose one from the quarter menu above.

Top 13 holdings · Q2 2024

Largest Q2 2024 13F positions by reported value
# Holding Reported value % of portfolio
1 FSTR FOSTER L B CO $28.3M 24.11%
2 LFCR LIFECORE BIOMEDICAL INC $24.0M 20.48%
3 ANEB ANEBULO PHARMACEUTICALS INC $14.6M 12.5%
4 STRL STERLING INFRASTRUCTURE INC $11.8M 10.07%
5 BBSI BARRETT BUSINESS SVCS INC $8.7M 7.41%
6 CULP CULP INC $5.5M 4.73%
7 PFX PHENIXFIN CORP $5.5M 4.7%
8 FARM FARMER BROS CO $5.2M 4.47%
9 DHX DHI GROUP INC $4.3M 3.69%
10 MTW MANITOWOC CO INC $4.1M 3.5%
11 LNTH LANTHEUS HLDGS INC $2.8M 2.37%
12 SSKN STRATA SKIN SCIENCES INC $1.6M 1.41%
13 PMDI PSYCHEMEDICS CORP $664.1K 0.57%

Values as reported on the Q2 2024 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings